Status: current, Defined. Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4361684010 | Administration of SARS-CoV-2 mRNA vaccine | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
4361685011 | 2019 novel coronavirus mRNA immunization | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
4361686012 | COVID-19 mRNA vaccination | en | Synonym | Active | Case sensitive | SNOMED CT core |
4361687015 | COVID-19 mRNA immunization | en | Synonym | Active | Case sensitive | SNOMED CT core |
4361688013 | 2019-nCoV mRNA immunization | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
4361689017 | COVID-19 mRNA immunisation | en | Synonym | Active | Case sensitive | SNOMED CT core |
4361690014 | 2019-nCoV mRNA immunisation | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
4361691013 | 2019-nCoV mRNA vaccination | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
4361692018 | SARS-CoV-2 mRNA vaccination | en | Synonym | Active | Case sensitive | SNOMED CT core |
4361693011 | SARS-CoV-2 mRNA immunisation | en | Synonym | Active | Case sensitive | SNOMED CT core |
4361694017 | 2019 novel coronavirus mRNA immunisation | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
4361695016 | Severe acute respiratory syndrome coronavirus 2 mRNA vaccination | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
4361696015 | 2019 novel coronavirus mRNA vaccination | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
4361698019 | SARS-CoV-2 mRNA immunization | en | Synonym | Active | Case sensitive | SNOMED CT core |
4669642012 | Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
4669643019 | Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Administration of SARS-CoV-2 mRNA vaccine | Is a | Active immunisation | false | Inferred relationship | Some | ||
Administration of SARS-CoV-2 mRNA vaccine | Direct substance | SARS-CoV-2 mRNA vaccine | true | Inferred relationship | Some | 1 | |
Administration of SARS-CoV-2 mRNA vaccine | Method | Administration - action | true | Inferred relationship | Some | 1 | |
Administration of SARS-CoV-2 mRNA vaccine | Is a | Administration of SARS-CoV-2 vaccine | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Administration of first dose of SARS-CoV-2 mRNA vaccine | Is a | True | Administration of SARS-CoV-2 mRNA vaccine | Inferred relationship | Some | |
Administration of second dose of SARS-CoV-2 mRNA vaccine | Is a | True | Administration of SARS-CoV-2 mRNA vaccine | Inferred relationship | Some | |
SARS-CoV-2 mRNA vaccine contraindicated | Associated procedure | True | Administration of SARS-CoV-2 mRNA vaccine | Inferred relationship | Some | 1 |
SARS-CoV-2 mRNA vaccination not indicated | Associated procedure | True | Administration of SARS-CoV-2 mRNA vaccine | Inferred relationship | Some | 1 |
SARS-CoV-2 mRNA vaccine declined | Associated procedure | True | Administration of SARS-CoV-2 mRNA vaccine | Inferred relationship | Some | 1 |
Second dose of SARS-CoV-2 mRNA vaccine declined | Associated procedure | False | Administration of SARS-CoV-2 mRNA vaccine | Inferred relationship | Some | 1 |
Reference Sets
Procedure foundation reference set
Unit of use quantity reference set